Skip to main content
Log in

Substantial practice variation exists in the management of childhood nephrotic syndrome

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Background

Practice variation is common for nephrotic syndrome (NS) treatment.

Methods

A cross-sectional, web-based survey on NS treatment was administered to 58 Canadian pediatric nephrologists with the aim to document existing practice variation and compare practice with the recommendations of the Kidney Disease Improving Global Outcomes Clinical Practice Guideline for NS.

Results

Of the 58 nephrologists asked to participate in the survey, 40 (69 %) responded. Among these, 62 % prescribed initial daily glucocorticoid (GC) therapy for 6 weeks, 26 % for 4 weeks by 26 %, and 10 % prescribed ‘other’. Alternate-day GC was continued for 6 weeks by 63 % of respondents and for >6 and <6 weeks by 32 and 6 %, respectively. For biopsy-confirmed minimal change disease, 65 and 46 % of respondents chose oral cyclophosphamide for frequently relapsing and steroid-dependent phenotypes, respectively; calcineurin inhibitors or mycophenolate were the second most popular choices. Kidney biopsy was ‘always’ performed by 16, 39, and 97 % of respondents for frequently relapsing, steroid-dependent, and steroid-resistant patients, respectively. Rituximab had been administered by 60 % of respondents; 22, 56, and 72 % reported that they would consider rituximab for frequently relapsing, steroid-dependent, and steroid-resistant patients, respectively. Most notable differences between practice and Guideline recommendations were first presentation GC duration, GC-sparing agent choices in frequently relapsing and steroid-dependent patients, and biopsy practices.

Conclusions

There is substantial Canadian practice variation in NS treatment. Assessment of factors driving variation and strategies to implement Guideline recommendations are needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Gipson DS, Massengill SF, Yao L, Nagaraj S, Smoyer WE, Mahan JD, Wigfall D, Miles P, Powell L, Lin JJ, Trachtman H, Greenbaum LA (2009) Management of childhood onset nephrotic syndrome. Pediatrics 124:747–757

    Article  PubMed  Google Scholar 

  2. Churg J, Habib R, White RH (1970) Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. Lancet 760:1299–1302

    Article  PubMed  CAS  Google Scholar 

  3. Churg J, Habib R, White RH (1979) Alternate-day versus intermittent prednisone in frequently relapsing nephrotic syndrome. A report of "Arbetsgemeinschaft fur Padiatrische Nephrologie". Lancet 1:401–403

    Google Scholar 

  4. Ehrich JH, Brodehl J (1993) Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft fur Padiatrische Nephrologie. Eur J Pediatr 152:357–361

    Article  PubMed  CAS  Google Scholar 

  5. Lande MB, Leonard MB (2000) Variability among pediatric nephrologists in the initial therapy of nephrotic syndrome. Pediatr Nephrol 14:766–769

    Article  PubMed  CAS  Google Scholar 

  6. MacHardy N, Miles PV, Massengill SF, Smoyer WE, Mahan JD, Greenbaum L, Massie S, Yao L, Nagaraj S, Lin JJ, Wigfall D, Trachtman H, Hu Y, Gipson DS (2009) Management patterns of childhood-onset nephrotic syndrome. Pediatr Nephrol 24:2193–2201

    Article  PubMed  Google Scholar 

  7. Hodson EM, Willis NS, Craig JC (2008) Non-corticosteroid treatment for nephrotic syndrome in children. Cochrane Database Syst Rev (1):CD002290. doi:10.1002/14651858.CD002290.pub3

  8. Haute Autorité de Santé (2008) Syndrome néphrotique idiopathique de l’enfant. Protocol national de diagnostic et de soins pour une maladie rare. Haute Autorité de Santé, Saint-Denis La Plaine, pp 1–22. Available at: www.has-sante.fr

  9. Bagga A, Ali U, Banerjee S, Kanitkar M, Phadke KD, Senguttuvan P, Sethi S, Shah M (2008) Management of steroid sensitive nephrotic syndrome: revised guidelines. Indian Pediatr 45:203–214

    PubMed  Google Scholar 

  10. Kidney Disease Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group (2012) KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl 2:139–274

    Article  Google Scholar 

  11. Graham ID, Logan J, Harrison MB, Straus SE, Tetroe J, Caswell W, Robinson N (2006) Lost in knowledge translation: time for a map? J Contin Educ Health Prof 26:13–24

    Article  PubMed  Google Scholar 

  12. Grol R (2001) Improving the quality of medical care: building bridges among professional pride, payer profit, and patient satisfaction. JAMA 286:2578–2585

    Article  PubMed  CAS  Google Scholar 

  13. McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A, Kerr EA (2003) The quality of health care delivered to adults in the United States. N Engl J Med 348:2635–2645

    Article  PubMed  Google Scholar 

  14. Straus SE, Tetroe J, Graham I (2009) Defining knowledge translation. CMAJ 181:165–168

    Article  PubMed  Google Scholar 

  15. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 147:573–577

    Article  Google Scholar 

  16. Hodson EM, Willis NS, Craig JC (2007) Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev (1):CD001533. doi:10.1002/14651858.CD002290.pub3.

  17. Hirano D, Nishizaki N, Kanai H, Hara S, Ohtomo Y, Umino D, Fujinaga S (2010) Long-term outcome of children treated with the ISKDC regimen for the first episode of INS. Nihon Jinzo Gakkai Shi 52:1029–1036

    PubMed  Google Scholar 

  18. Hussain F, Mallik M, Marks SD, Watson AR (2010) Renal biopsies in children: current practice and audit of outcomes. Nephrol Dial Transplant 25:485–489

    Article  PubMed  Google Scholar 

  19. Magnasco A, Ravani P, Edefonti A, Murer L, Ghio L, Belingheri M, Benetti E, Murtas C, Messina G, Massella L, Porcellini MG, Montagna M, Regazzi M, Scolari F, Ghiggeri GM (2012) Rituximab in children with resistant idiopathic nephrotic syndrome. J Am Soc Nephrol 23:1117–1124

    Article  PubMed  CAS  Google Scholar 

  20. Eddy AA, Symons JM (2003) Nephrotic syndrome in childhood. Lancet 362:629–639

    Article  PubMed  Google Scholar 

  21. Greenbaum LA, Benndorf R, Smoyer WE (2012) Childhood nephrotic syndrome–current and future therapies. Nat Rev Nephrol 8:445–458

    Article  PubMed  CAS  Google Scholar 

  22. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR (1999) Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA 282:1458–1465

    Article  PubMed  CAS  Google Scholar 

  23. Grimshaw JM, Shirran L, Thomas R, Mowatt G, Fraser C, Bero L, Grilli R, Harvey E, Oxman A, O’Brien MA (2001) Changing provider behavior: an overview of systematic reviews of interventions. Med Care 39:II2–45

    Article  PubMed  CAS  Google Scholar 

  24. Campbell H, Hotchkiss R, Bradshaw N, Porteous M (1998) Integrated care pathways. BMJ 316:133–137

    Article  PubMed  CAS  Google Scholar 

  25. Panella M, Marchisio S, Di Stanislao F (2003) Reducing clinical variations with clinical pathways: do pathways work? Int J Qual Health Care 15:509–521

    Article  PubMed  CAS  Google Scholar 

  26. Rotter T, Kinsman L, James E, Machotta A, Gothe H, Willis J, Snow P, Kugler J (2010) Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs. Cochrane Database Syst Rev (3):CD006632. doi:10.1002/14651858.CD006632.pub2

Download references

Acknowledgments

We sincerely thank all the Canadian pediatric nephrologists who completed the online survey regarding their management practices in childhood nephrotic syndrome. We gratefully acknowledge the support provided by the Canadian Kidney Knowledge Translation and Generation Network and the Canadian Association of Pediatric Nephrologists in the conduct and completion of this study.

Disclosures (funding)

SS received salary award support from the Kidney Research Scientist Core Education and National Training Program (Kidney Foundation of Canada, Canadian Institutes for Health Research, Canadian Society of Nephrology) and Canadian Child Health Clinician Scientist Program. MZ received salary support from the Fonds de Recherche du Québec–Santé.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael Zappitelli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Samuel, S., Morgan, C.J., Bitzan, M. et al. Substantial practice variation exists in the management of childhood nephrotic syndrome. Pediatr Nephrol 28, 2289–2298 (2013). https://doi.org/10.1007/s00467-013-2546-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-013-2546-0

Keywords

Navigation